Aureus Asset Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Aureus Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$38.89 - $77.3 $152,448 - $303,016	-3,920 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$71.81 - $90.15 $2.72 Million - $3.42 Million	-37,898 Reduced 90.63%	3,920 $299,000
Q2 2018 Aug 13, 2018	BUY	$48.54 - $85.31 $188,820 - $331,855	3,890 Added 10.26%	41,818 $3.22 Million
Q1 2018 May 15, 2018	SELL	$44.33 - $58.52 $104,618 - $138,107	-2,360 Reduced 5.86%	37,928 $1.93 Million
Q4 2017 Feb 14, 2018	SELL	$43.54 - $57.32 $819,727 - $1.08 Million	-18,827 Reduced 31.85%	40,288 $1.87 Million
Q3 2017 Nov 13, 2017	BUY	$49.79 - $66.32 $2.94 Million - $3.92 Million	59,115	59,115 $3.15 Million

325

85.5M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.14B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aureus Asset Management, LLC with notifications on news.